New adjuvants in evolving vaccine strategies

Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3

(2014) H. Li et al.   JOURNAL OF IMMUNOLOGY

Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile

(2011) Nathalie Garçon et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Influenza virosomes as a vaccine adjuvant and carrier system

(2011) Christian Moser et al.   Expert Review of Vaccines

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

(2011) Rhea N. Coler et al.   PLoS One

TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin

(2010) Matam Vijay-Kumar et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

PharmaPlant: the new frontier in vaccines

(2010) Franco M Buonaguro et al.   Expert Review of Vaccines

Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults

(2010) Jiří Beran et al.   Human vaccines & immunotherapeutics

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

Flagellin as an Adjuvant: Cellular Mechanisms and Potential

(2010) S. B. Mizel et al.   JOURNAL OF IMMUNOLOGY

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference

(2010) Anna Laura Ross et al.   LANCET INFECTIOUS DISEASES

DAI (DLM-1/ZBP1) as a Genetic Adjuvant for DNA Vaccines That Promotes Effective Antitumor CTL Immunity

(2010) Alvaro Lladser et al.   MOLECULAR THERAPY

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults

(2010) John J. Treanor et al.   VACCINE

Virus-like particle vaccines and adjuvants: the HPV paradigm

(2009) Franco Maria Buonaguro et al.   Expert Review of Vaccines

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity

(2009) A. M. Didierlaurent et al.   JOURNAL OF IMMUNOLOGY

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

(2009) Kent E. Kester et al.   JOURNAL OF INFECTIOUS DISEASES

Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs

(2009) L. Bousarghin et al.   MOLECULAR CANCER THERAPEUTICS

The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex

(2009) Beom Seok Park et al.   NATURE

ISCOMs and ISCOMATRIX™

(2009) Hong-Xiang Sun et al.   VACCINE

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

(2009) Iván D. Vélez et al.   VACCINE

Mechanism of action of licensed vaccine adjuvants

(2009) Elaine Tritto et al.   VACCINE

Synthesis of Thin and Highly Conductive DNA-Based Palladium Nanowires

(2008) Khoa Nguyen et al.   ADVANCED MATERIALS

Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model

(2008) R. GASPARINI et al.   EPIDEMIOLOGY AND INFECTION

Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients

(2008) Jiri Beran   EXPERT OPINION ON BIOLOGICAL THERAPY

Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding

(2008) Sjoerd H van der Burg   Expert Review of Vaccines

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature

(2008) Tino F. Schwarz et al.   GYNECOLOGIC ONCOLOGY

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

(2008) Mary K. Wloch et al.   JOURNAL OF INFECTIOUS DISEASES

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2

(2008) H. H. Alphs et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunobiology of Human Papillomavirus Infection and Vaccination - Implications for Second Generation Vaccines

(2008) Margaret Stanley et al.   VACCINE

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

(2008) Thomas Verstraeten et al.   VACCINE

New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin

(2008) Daniel Y. Bargieri et al.   VACCINE